Fludeoxyglucose F18

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 69864-001
  • Package NDC 69864-001-30
  • Application number ANDA203904
  • SPL ID c961907a-db84-c6f2-e053-2995a90aefd2
  • SPL set ID 195d1b07-5669-247f-e054-00144ff8d46c
  • UNII 0Z5B2CJX4D

What the source publishes

Labeler
The Methodist Hospital Research Institute
Active ingredients
Fludeoxyglucose F18
Form
INJECTION, SOLUTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:69864-001_c961907a-db84-c6f2-e053-2995a90aefd2
{
  "name": "Fludeoxyglucose F18",
  "splId": "c961907a-db84-c6f2-e053-2995a90aefd2",
  "labels": [
    {
      "setId": "195d1b07-5669-247f-e054-00144ff8d46c",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=195d1b07-5669-247f-e054-00144ff8d46c",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=195d1b07-5669-247f-e054-00144ff8d46c"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "The Methodist Hospital Research Institute",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 mL in 1 VIAL, MULTI-DOSE (69864-001-30)",
      "package_ndc": "69864-001-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20120423"
    }
  ],
  "productId": "69864-001_c961907a-db84-c6f2-e053-2995a90aefd2",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "69864-001",
  "deaSchedule": null,
  "genericName": "Fludeoxyglucose F18",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "FLUDEOXYGLUCOSE F-18",
      "strength": ".3 Ci/mL"
    }
  ],
  "applicationNumber": "ANDA203904",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20120423",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000177914",
      "N0000000205"
    ],
    "unii": [
      "0Z5B2CJX4D"
    ],
    "spl_set_id": [
      "195d1b07-5669-247f-e054-00144ff8d46c"
    ],
    "pharm_class_epc": [
      "Radioactive Diagnostic Agent [EPC]"
    ],
    "pharm_class_moa": [
      "Radiopharmaceutical Activity [MoA]"
    ],
    "manufacturer_name": [
      "The Methodist Hospital Research Institute"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:69864-001_c961907a-db84-c6f2-e053-2995a90aefd2"